Market Research Logo

Central Nervous System Drugs Global Market Report 2018 Including: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-EpilepticsCovering: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG

Central Nervous System Drugs Global Market Report 2018 Including: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-EpilepticsCovering: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG

Central Nervous System Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The central nervous system drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Central Nervous System Drugs Indicators Comparison.

Scope

Markets Covered: Other CNS drugs ; Anaesthetics; Analgesics; Anti-Parkinson drugs; Anti-Epileptics

Companies Mentioned: Biogen Inc,F. Hoffmann-La Roche Ltd,Johnson & Johnson,Pfizer Inc,Novartis AG

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Central Nervous System Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Central Nervous System Drugs Market Characteristics
2. Central Nervous System Drugs Market Size And Growth
2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth, Value ($ Billion)
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market;
3. Central Nervous System Drugs Trends And Strategies;
4. Pestle Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental;
5. Central Nervous System Drugs Market Customer Information;
6. Central Nervous System Drugs Market Regional And Country Analysis
6.1. Global Central Nervous System Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
6.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Region
6.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
6.4. Global Central Nervous System Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
6.5. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Country
6.6. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Country
7. Central Nervous System Drugs Market Segmentation
7.1. Global Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
7.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
8. Central Nervous System Drugs Market Segments
8.1.Other CNS drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Other CNS drugs Market, 2017, By Segment, Value ($ Billion)
8.2.Anaesthetics
a) Market Characteristics
b) Market Trends & Strategies
c) Global Anaesthetics Market, 2017, By Segment, Value ($ Billion)
8.3.Analgesics
a) Market Characteristics
b) Market Trends & Strategies
c) Global Analgesics Market, 2017, By Segment, Value ($ Billion)
8.4.Anti-Parkinson drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Anti-Parkinson drugs Market, 2017, By Segment, Value ($ Billion)
8.5.Anti-Epileptics
a) Market Characteristics
b) Market Trends & Strategies
c) Global Anti-Epileptics Market, 2017, By Segment, Value ($ Billion)
9. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors
9.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
9.2. Per Capita Average Central Nervous System Drugs Expenditure, Global
10. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries
10.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country
10.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country
11. Central Nervous System Drugs Market Comparison With Industry Metrics
11.1. Global Number Of Pharmacists, 2017, By Country
11.2. Global Central Nervous System Market Revenue Versus Number Of Pharmacists, 2017, By Country
11.3. Global Number Of Pharma Enterprises, 2017, By Country
11.4. Global Central Nervous System Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
11.5. Global Average Spending On R&D/Product Development, 2017, By Country
11.6. Global Central Nervous System Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
11.8. Global Central Nervous System Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
11.9. Prevalent Cases Of Parkinsons Disease, 2014, By Country
11.10. Global Number Of Psychiatrists, 2017, By Country
11.11. Global Central Nervous System Market Revenue Versus Number Of Psychiatrists, 2017, By Country
11.12. Global Number Of General Practitioners 2017, By Country
11.13. Global Central Nervous System Market Revenue Versus Number Of General Practitioners, 2017, By Country
12. Asia-Pacific Central Nervous System Drugs Market
12.1.1. Asia-Pacific Central Nervous System Drugs Market Overview
12.1.2. Asia-Pacific Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.1.3. Asia-Pacific Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.1.4. Asia-Pacific Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
12.1.5. Asia-Pacific Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.2. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
12.3. China Central Nervous System Drugs Market
12.3.1. China Central Nervous System Drugs Market Overview
12.3.2. China Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.3.3. China Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.3.4. China Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
12.3.5. China Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.4. India Central Nervous System Drugs Market
12.4.1. India Central Nervous System Drugs Market Overview
12.4.2. India Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.4.3. India Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.4.4. India Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
12.4.5. India Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.5. Japan Central Nervous System Drugs Market
12.5.1. Japan Central Nervous System Drugs Market Overview
12.5.2. Japan Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.5.3. Japan Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.5.4. Japan Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
12.5.5. Japan Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.6. Australia Central Nervous System Drugs Market
12.6.1. Australia Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.6.2. Australia Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.6.3. Australia Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
12.6.4. Australia Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13. Western Europe Central Nervous System Drugs Market
13.1.1. Western Europe Central Nervous System Drugs Market Overview
13.1.2. Western Europe Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.1.3. Western Europe Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.1.4. Western Europe Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
13.1.5. Western Europe Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.2. Western Europe Central Nervous System Drugs Market: Country Analysis
13.3. UK Central Nervous System Drugs Market
13.3.1. UK Central Nervous System Drugs Market Overview
13.3.2. UK Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.3.3. UK Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.3.4. UK Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
13.3.5. UK Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.4. Germany Central Nervous System Drugs Market
13.4.1. Germany Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.4.2. Germany Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.4.3. Germany Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
13.4.4. Germany Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.5 France Central Nervous System Drugs Market
13.5.1 France Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.5.2 France Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.5.3. France Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
13.5.4. France Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.6. Italy Central Nervous System Drugs Market
13.6.1. Italy Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.6.2. Italy Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.6.3. Italy Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
13.6.4. Italy Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.7. Spain Central Nervous System Drugs Market
13.7.1. Spain Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.7.2. Spain Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.7.3. Spain Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
13.7.4. Spain Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14. Eastern Europe Central Nervous System Drugs Market
14.1.1. Eastern Europe Central Nervous System Drugs Market Overview
14.1.2. Eastern Europe Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.1.3. Eastern Europe Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
14.1.4. Eastern Europe Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
14.1.5. Eastern Europe Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14.2. Eastern Europe Central Nervous System Drugs Market: Country Analysis
14.3. Russia Central Nervous System Drugs Market
14.3.1. Russia Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.3.2. Russia Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
14.3.3. Russia Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
14.3.4. Russia Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15. North America Central Nervous System Drugs Market
15.1.1. North America Central Nervous System Drugs Market Overview
15.1.2. North America Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.1.3. North America Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
15.1.4. North America Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
15.1.5. North America Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.2. North America Central Nervous System Drugs Market: Country Analysis
15.3. USA Central Nervous System Drugs Market
15.3.1. USA Central Nervous System Drugs Market Overview
15.3.2. USA Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.3.3. USA Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
15.3.4. USA Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
15.3.5. USA Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16. South America Central Nervous System Drugs Market
16.1.1. South America Central Nervous System Drugs Market Overview
16.1.2. South America Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.1.3. South America Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
16.1.4. South America Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
16.1.5. South America Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16.2. South America Central Nervous System Drugs Market: Country Analysis
16.3. Brazil Central Nervous System Drugs Market
16.3.1. Brazil Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.3.2. Brazil Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
16.3.3. Brazil Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
16.3.4. Brazil Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
17. Middle East Central Nervous System Drugs Market
17.1.1. Middle East Central Nervous System Drugs Market Overview
17.1.2. Middle East Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
17.1.3. Middle East Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
17.1.4. Middle East Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
17.1.5. Middle East Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
18. Africa Central Nervous System Drugs Market
18.1.1. Africa Central Nervous System Drugs Market Overview
18.1.2. Africa Central Nervous System Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
18.1.3. Africa Central Nervous System Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
18.1.4. Africa Central Nervous System Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Other CNS drugs
Anaesthetics
Analgesics
Anti-Parkinson drugs
Anti-Epileptics
18.1.5. Africa Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
19. Central Nervous System Drugs Market Competitive Landscape
19.1. Company Profiles
19.2. Biogen Inc
19.2.1. Overview
19.2.2. Products And Services
19.2.3. Strategy
19.2.4. Financial Performance
19.3. F. Hoffmann-La Roche Ltd
19.3.1. Overview
19.3.2. Products And Services
19.3.3. Strategy
19.3.4. Financial Performance
19.4. Johnson & Johnson
19.4.1. Overview
19.4.2. Products And Services
19.4.3. Strategy
19.4.4. Financial Performance
19.5. Pfizer Inc
19.5.1. Overview
19.5.2. Products And Services
19.5.3. Strategy
19.5.4. Financial Performance
19.6. Novartis AG
19.6.1. Overview
19.6.2. Products And Services
19.6.3. Strategy
19.6.4. Financial Performance
20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
21. Market Background: Central Nervous System Drugs Market
21.1.1. Central Nervous System Drugs Market Characteristics
21.1.2. Central Nervous System Drugs Market Historic Growth, Value ($ Billion)
21.1.2.1. Drivers Of The Market
21.1.2.2. Restraints Of The Market
21.1.3. Central Nervous System Drugs Market Forecast Growth, Value ($ Billion)
21.1.3.1. Drivers Of The Market
21.1.3.2. Restraints Of The Market
21.1.4. Central Nervous System Drugs Trends And Strategies
21.2. Central Nervous System Drugs Market Regional And Country Analysis
21.2.1. Global Central Nervous System Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
21.2.2. Global Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Region
21.2.3. Central Nervous System Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
21.2.4. Central Nervous System Drugs Market, 2013 - 2021, Historic And Forecast, By Country
21.2.5. Central Nervous System Drugs Market, Growth And Market Share Comparison, By Segment
21.2.6. Central Nervous System Drugs Market, Growth And Market Share Comparison, By Country And Segment
21.3. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors
21.3.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global
21.3.2. Per Capita Average Central Nervous System Drugs Expenditure, Global
21.4. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries
21.4.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country
21.4.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country
21.5. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
22. Appendix
22.1. NAICS Definitions Of Industry Covered In This Report
22.2. Abbreviations
22.3. Currencies
22.4. Research Inquiries
22.5. The Business Research Company
22.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report